PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Oxidronate→

Oxidronate PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
15468-10-7
Molecular formula
CH6O7P2
Molecular weight
192 g/mol
Drug class
Bisphosphonate liganddiagnostic radiopharmaceutical precursor for technetium-99m bone imaging
Mechanism of action
Oxidronate (hydroxymethylene diphosphonate, HMDP/HDP) chelates technetium-99m in radiopharmaceutical kits. The labelled complex localises to hydroxyapatite at sites of increased osteoblastic activity, permitting skeletal scintigraphy.
Indications / reported uses
  • Used as the active ligand in technetium-99m oxidronate (HDP/HMDP) for skeletal scintigraphy and assessment of areas of increased bone turnover. Diagnostic imaging uses the technetium-labelled formulation.

Sources: https://www.ncbi.nlm.nih.gov/mesh?term=%22technetium+Tc+99m+hydroxymethylene+diphosphonate%22 · https://www.ncbi.nlm.nih.gov/sites/books/NBK531486/ · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Oxidronate PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Oxidronate Permitted Daily Exposure (PDE) report (the Oxidronate PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Oxidronate Occupational Exposure Limit (OEL) report (the Oxidronate OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.